Neoprobe's Phase 3 Lymphoseek Study Reaches Accrual Goal

		HER2 Support Group Forums > Breast Cancer Newsfeed
Neoprobe's Phase 3 Lymphoseek Study Reaches Accrual Goal

02-17-2011, 04:15 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,960	Neoprobe's Phase 3 Lymphoseek Study Reaches Accrual Goal Neoprobe Corporation (NYSE: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, announced that a multi-center Phase 3 study of Lymphoseek® has enrolled clinical subjects to achieve the minimum analysis goal of 196 lymph nodes, the study's primary accrual objective... More...

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 09:13 AM.